- Home
- BZ vs EXAS Comparison
BZ vs EXAS Comparison
Compare BZ & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BZ
- EXAS
- Stock Information
- Founded
- BZ 2013
- EXAS 1995
- Country
- BZ China
- EXAS United States
- Employees
- BZ N/A
- EXAS N/A
- Industry
- BZ Computer Software: Programming Data Processing
- EXAS Medical Specialities
- Sector
- BZ Technology
- EXAS Health Care
- Exchange
- BZ Nasdaq
- EXAS Nasdaq
- Market Cap
- BZ 11.3B
- EXAS 10.2B
- IPO Year
- BZ 2021
- EXAS N/A
- Fundamental
- Price
- BZ $24.97
- EXAS $52.58
- Analyst Decision
- BZ Strong Buy
- EXAS Strong Buy
- Analyst Count
- BZ 5
- EXAS 22
- Target Price
- BZ $21.20
- EXAS $67.38
- AVG Volume (30 Days)
- BZ 4.6M
- EXAS 2.8M
- Earning Date
- BZ 08-20-2025
- EXAS 11-04-2025
- Dividend Yield
- BZ 0.68%
- EXAS N/A
- EPS Growth
- BZ 51.73
- EXAS N/A
- EPS
- BZ 0.66
- EXAS N/A
- Revenue
- BZ $1,083,348,363.00
- EXAS $2,939,949,000.00
- Revenue This Year
- BZ $15.37
- EXAS $16.68
- Revenue Next Year
- BZ $13.17
- EXAS $12.08
- P/E Ratio
- BZ $37.12
- EXAS N/A
- Revenue Growth
- BZ 14.01
- EXAS 12.55
- 52 Week Low
- BZ $12.06
- EXAS $38.81
- 52 Week High
- BZ $25.26
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- BZ 76.24
- EXAS 57.78
- Support Level
- BZ $24.10
- EXAS $46.30
- Resistance Level
- BZ $25.26
- EXAS $56.52
- Average True Range (ATR)
- BZ 0.61
- EXAS 1.67
- MACD
- BZ -0.02
- EXAS 0.27
- Stochastic Oscillator
- BZ 87.98
- EXAS 61.45
About BZ KANZHUN LIMITED American Depository Shares
Kanzhun's Boss Zhipin job platform connects job seekers and employers. Boss Zhipin is China's largest online recruitment platform based on monthly active users, or MAU, and was established in 2014. Kanzhun earns revenue by providing services to enterprise customers primarily through its mobile app, which promotes engagement between recruiters and workers and operates on a recommendation basis powered by artificial intelligence. The platform specializes in transportation, logistics, construction, and service-based industries. About 85% of the companies looking to hire are small and medium-size enterprises. Its main competitors are 58.com, 51job, and Zhilian Zhaopin. Tencent has a 9.2% stake in Kanzhun.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.